Moreover, the knockdown of GP73 triggered SAPK/JNK and p53‐p21 signalling pathways inhibition, which modulated the equilibrium of intracellular MMP‐2 by regulating the transactivation of MMP2. These studies provided a potential target for combating metastatic HCC. This evidence concerns the gene MMP2 and hepatocellular carcinoma.